Literature DB >> 9405163

Signaling pathways in cardiac myocyte hypertrophy.

M A Hefti1, B A Harder, H M Eppenberger, M C Schaub.   

Abstract

When a heart responds to increased workload it does so by hypertrophy. This is characterized by an increase in cell size in the absence of cell division, and is accompanied by distinct qualitative and quantitative changes in gene expression. The use of cardiomyocytes in cell culture has identified, besides mechanical loading, a range of substances, such as cytokines, growth factors, catecholamines, vasoactive peptides and hormones, involved in mediating cardiac myocyte hypertrophy, and has enabled the molecular dissection of the pathways involved in signal transduction. Many different pathways are activated in response to different hypertrophic stimuli, and a growing number of crosslinks are being characterized between these pathways. Recent evidence suggests a central role for Ras in transmitting signals from G-protein coupled receptors, from growth factor receptors and from cytokine receptors not only down the Raf-MEK-ERK pathway to the nucleus, but also to various other cytosolic effectors. The evaluation of distinct morphological phenotypes, together with biochemical data on gene regulation, suggests that interactions between different signaling pathways take place. Each stimulus provokes a typical cellular phenotype and different stimuli may act alone or in concert in a synergistic, antagonistic or permissive manner. Consequently, hypertrophy of cultured cardiomyocytes cannot simply be characterized as the reversal to the fetal gene expression program. Thus, hypertrophic growth of the heart may similarly be the result of a complex combinatorial action of various stimuli, which may also lead to different morphological and biochemical phenotypes with distinct physiological properties. Copyright 1997 Academic Press Limited.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9405163     DOI: 10.1006/jmcc.1997.0523

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  41 in total

1.  Regulation of Na/K-ATPase beta1-subunit gene expression by ouabain and other hypertrophic stimuli in neonatal rat cardiac myocytes.

Authors:  P Kometiani; J Tian; J Li; Z Nabih; G Gick; Z Xie
Journal:  Mol Cell Biochem       Date:  2000-12       Impact factor: 3.396

2.  Effects of aldosterone on transient outward K+ current density in rat ventricular myocytes.

Authors:  J P Bénitah; E Perrier; A M Gómez; G Vassort
Journal:  J Physiol       Date:  2001-11-15       Impact factor: 5.182

Review 3.  Signaling and cellular mechanisms in cardiac protection by ischemic and pharmacological preconditioning.

Authors:  Michael Zaugg; Marcus C Schaub
Journal:  J Muscle Res Cell Motil       Date:  2003       Impact factor: 2.698

4.  Role of the angiotensin II receptor blocker valsartan in heart failure.

Authors:  R L Webb; M de Gasparo
Journal:  Exp Clin Cardiol       Date:  2001

5.  Overexpression of angiotensin II type I receptor in cardiomyocytes induces cardiac hypertrophy and remodeling.

Authors:  P Paradis; N Dali-Youcef; F W Paradis; G Thibault; M Nemer
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-18       Impact factor: 11.205

6.  Differential effects of hypoxic and hyperoxic stress-induced hypertrophy in cultured chick fetal cardiac myocytes.

Authors:  Allison A Greco; George Gomez
Journal:  In Vitro Cell Dev Biol Anim       Date:  2013-08-29       Impact factor: 2.416

Review 7.  Myofibrillar remodeling in cardiac hypertrophy, heart failure and cardiomyopathies.

Authors:  Jarmila Machackova; Judit Barta; Naranjan S Dhalla
Journal:  Can J Cardiol       Date:  2006-09       Impact factor: 5.223

8.  Effect of sodium tanshinone II A sulfonate on cardiac myocyte hypertrophy and its underlying mechanism.

Authors:  Jun Feng; Zhi Zheng
Journal:  Chin J Integr Med       Date:  2008-10-14       Impact factor: 1.978

Review 9.  Mathematical modeling of cardiac growth and remodeling.

Authors:  L C Lee; G S Kassab; J M Guccione
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2016-03-07

10.  Hypertensive state, independent of hypertrophy, exhibits an attenuated decrease in systolic function on cardiac kappa-opioid receptor stimulation.

Authors:  Craig Bolte; Gilbert Newman; Jo El J Schultz
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-01-30       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.